You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Loading...

About Innovative Vision Products


 1_welcome.jpg

Welcome to Innovative Vision Products (IVP), an intellectual and scientific research group under   the guidance Katerina Matiushina MD-Ph.D
Innovative Vision Products, Inc. was founded by Dr. Mark Babizhayev, Ph.D on the 12 November, 1998. 

IVP specializes in ophthalmic and pharmaceutical products, healthcare, fine cosmetics and nanotechnology.

IVP specializes.jpg

Our studies have been incorporated into products and protocols for organizations based in the USA, the United Kingdom, Italy, Monaco, Russia, Japan and Bulgaria   and we are holders of numerous patents. 

Our research.jpg

 We have active publication strategy and believe that prosperity and scientific excellence go hand in hand. Once the intellectual property rights are secured we will   immediately publish results of our research in top international scientific journals and start promoting our products.

 Innovative Vision Products, Ltd. was registered in Bulgaria 18 September, 2020 for active promotion of our developed and approved products.
   
 We collaborate with various research laboratories and pharmaceutical manufacturers around the world and are ready to expand our business partnerships.
 Our major interest is the application of biologically active peptide based compounds and peptidomimetics as novel therapeutic tools.

formulas_update.jpg 

 Among our recent discoveries is the role of natural di-peptide N-acetylcarnosine in treatment of human senile cataract. This has aroused a lot of interest because   we are the first group to prove that this age related disorder can be improved by eye-drops, in some cases without surgical intervention.

IVP_aged people.jpg 

 Furthermore, cataract can also be effectively treated in canines and pets in veterinary ophthalmology with our patented formula of N-acetylcarnosine eye drops.

IVP_animals.jpg

 IVP is a market research company - from our patented studies we promote our inventions worldwide through distributors, licensees and joint ventures. We have   developed the worldwide-patented N-acetylcarnosine ophthalmic product - this is now registered as the CE marked medical device in all countries of the EU.

We have now created a unique formulation "CanB-CanCarosine" with the bioavailable natural dipeptide L-Carnosine, manufactured in a GMP-certified facility,   containing a combination of substances that promote breathing, improve lung function during a period of the seasonal diseases such as influenza, colds, acute   respiratory diseases and coronavirus infections. It is registered as a food supplement in Bulgaria.